{"id":{"repo_id":"calpoly","oai_identifier":"oai:digitalcommons.calpoly.edu:theses-4586"},"canonical_url":"https://search.ndltd.org/etd/calpoly/oai:digitalcommons.calpoly.edu:theses-4586","repository":{"repo_id":"calpoly","name":"Cal Poly","base_url":"https://digitalcommons.calpoly.edu/do/oai/"},"display":{"title":"Using Noninvasive Calibrated Cuff Plethysmography to Observe the Effects of Diabetes on Arterial Compliance","abstract":"The prevalence of cardiovascular disease is on a continuous exponential growth across the globe. Thus, research into the underlying factors, effective methods of diagnoses, and preventive measures is necessary. Endothelial dysfunction is an early detector of cardiovascular diseases and can be used to inform people of preventative measures and early treatments before any extreme medical conditions occur. Something that is also on the rise and closely linked with cardiovascular disease is diabetes. There have been many past research studies that show the impact of diabetes on cardiovascular disease and more specifically endothelial dysfunction. A calibrated cuff plethysmography device is a promising solution to measure endothelial function by specifically looking at the arterial compliance of certain blood vessels. IN this study, a calibrated cuff plethysmography device was used to test for the impact diabetes has on arterial compliance. Although the results did not show significant differences between the diabetic and control group it shows trends that we would expect from previous studies and is promising for more research. In this study the results showed no statistically significant difference between the diabetics and non-diabetics with a p-value of 0.805677 for the 0 mmHg – 75 mmHg range and a p-value of 0.668734 for the 25 mmHg – 75 mmHg range. However, when comparing the baseline measurements to the hyperemia measurements for the 0 mmHg – 75 mmHg range there was a statistically significant difference with a p-value of 0.0034 for diabetics and a p-value of 0.04347 for the non-diabetics. Given this statistically significant difference, the device used was concluded to effectively measure arterial compliance and area.","abstract_html":"The prevalence of cardiovascular disease is on a continuous exponential growth across the globe. Thus, research into the underlying factors, effective methods of diagnoses, and preventive measures is necessary. Endothelial dysfunction is an early detector of cardiovascular diseases and can be used to inform people of preventative measures and early treatments before any extreme medical conditions occur. Something that is also on the rise and closely linked with cardiovascular disease is diabetes. There have been many past research studies that show the impact of diabetes on cardiovascular disease and more specifically endothelial dysfunction. A calibrated cuff plethysmography device is a promising solution to measure endothelial function by specifically looking at the arterial compliance of certain blood vessels. IN this study, a calibrated cuff plethysmography device was used to test for the impact diabetes has on arterial compliance. Although the results did not show significant differences between the diabetic and control group it shows trends that we would expect from previous studies and is promising for more research. In this study the results showed no statistically significant difference between the diabetics and non-diabetics with a p-value of 0.805677 for the 0 mmHg – 75 mmHg range and a p-value of 0.668734 for the 25 mmHg – 75 mmHg range. However, when comparing the baseline measurements to the hyperemia measurements for the 0 mmHg – 75 mmHg range there was a statistically significant difference with a p-value of 0.0034 for diabetics and a p-value of 0.04347 for the non-diabetics. Given this statistically significant difference, the device used was concluded to effectively measure arterial compliance and area.","abstract_has_math":false,"creators":["Bradford, Jadon"],"institution":null,"degree_name":"MS in Biomedical Engineering","degree_level":null,"degree_discipline":"Biomedical Engineering","degree_department":null,"school":null,"contributors":["Michael Whitt","Biomedical Engineering","College of Engineering"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:12:29Z","subjects":["calibrated cuff plethysmography","oscillometry","diabetes","reactive hyperemia","endothelial dysfunction","atherogenesis"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.calpoly.edu/theses/2954","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.calpoly.edu/theses/2954","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.calpoly.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.calpoly.edu%3Atheses-4586","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Michael Whitt","Biomedical Engineering","College of Engineering"]},{"key":"dc:creator","label":"Author","values":["Bradford, Jadon"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-11-10T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2024-11-01T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biomedical Engineering"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS in Biomedical Engineering"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["calibrated cuff plethysmography","oscillometry","diabetes","reactive hyperemia","endothelial dysfunction","atherogenesis"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.calpoly.edu/theses/2954"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The prevalence of cardiovascular disease is on a continuous exponential growth across the globe. Thus, research into the underlying factors, effective methods of diagnoses, and preventive measures is necessary. Endothelial dysfunction is an early detector of cardiovascular diseases and can be used to inform people of preventative measures and early treatments before any extreme medical conditions occur. Something that is also on the rise and closely linked with cardiovascular disease is diabetes. There have been many past research studies that show the impact of diabetes on cardiovascular disease and more specifically endothelial dysfunction. A calibrated cuff plethysmography device is a promising solution to measure endothelial function by specifically looking at the arterial compliance of certain blood vessels. IN this study, a calibrated cuff plethysmography device was used to test for the impact diabetes has on arterial compliance. Although the results did not show significant differences between the diabetic and control group it shows trends that we would expect from previous studies and is promising for more research. In this study the results showed no statistically significant difference between the diabetics and non-diabetics with a p-value of 0.805677 for the 0 mmHg – 75 mmHg range and a p-value of 0.668734 for the 25 mmHg – 75 mmHg range. However, when comparing the baseline measurements to the hyperemia measurements for the 0 mmHg – 75 mmHg range there was a statistically significant difference with a p-value of 0.0034 for diabetics and a p-value of 0.04347 for the non-diabetics. Given this statistically significant difference, the device used was concluded to effectively measure arterial compliance and area."]},{"key":"dc:title","label":"Title","values":["Using Noninvasive Calibrated Cuff Plethysmography to Observe the Effects of Diabetes on Arterial Compliance"]}]}],"canonical_facts":{"dc:contributor":["Michael Whitt","Biomedical Engineering","College of Engineering"],"dc:creator":["Bradford, Jadon"],"dc:date.available":["2024-11-10T08:00:00Z"],"dc:date.created":["2024-11-01T07:00:00Z"],"dc:description.abstract":["The prevalence of cardiovascular disease is on a continuous exponential growth across the globe. Thus, research into the underlying factors, effective methods of diagnoses, and preventive measures is necessary. Endothelial dysfunction is an early detector of cardiovascular diseases and can be used to inform people of preventative measures and early treatments before any extreme medical conditions occur. Something that is also on the rise and closely linked with cardiovascular disease is diabetes. There have been many past research studies that show the impact of diabetes on cardiovascular disease and more specifically endothelial dysfunction. A calibrated cuff plethysmography device is a promising solution to measure endothelial function by specifically looking at the arterial compliance of certain blood vessels. IN this study, a calibrated cuff plethysmography device was used to test for the impact diabetes has on arterial compliance. Although the results did not show significant differences between the diabetic and control group it shows trends that we would expect from previous studies and is promising for more research. In this study the results showed no statistically significant difference between the diabetics and non-diabetics with a p-value of 0.805677 for the 0 mmHg – 75 mmHg range and a p-value of 0.668734 for the 25 mmHg – 75 mmHg range. However, when comparing the baseline measurements to the hyperemia measurements for the 0 mmHg – 75 mmHg range there was a statistically significant difference with a p-value of 0.0034 for diabetics and a p-value of 0.04347 for the non-diabetics. Given this statistically significant difference, the device used was concluded to effectively measure arterial compliance and area."],"dc:identifier":["https://digitalcommons.calpoly.edu/theses/2954"],"dc:subject":["calibrated cuff plethysmography","oscillometry","diabetes","reactive hyperemia","endothelial dysfunction","atherogenesis"],"dc:title":["Using Noninvasive Calibrated Cuff Plethysmography to Observe the Effects of Diabetes on Arterial Compliance"],"thesis:degree_discipline":["Biomedical Engineering"],"thesis:degree_name":["MS in Biomedical Engineering"]},"updated_at":"2026-11-19T07:12:29Z"}